You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 39 No. 5, May 1982 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Clorgyline

A New Treatment for Patients With Refractory Rapid-Cycling Disorder

William Z. Potter, MD, PhD; Dennis L. Murphy, MD; Thomas A. Wehr, MD; Markku Linnoila, MD, PhD; Frederick K. Goodwin, MD

Arch Gen Psychiatry. 1982;39(5):505-510.


Abstract

• Five women with primary, major, bipolar affective disorder, characterized by rapid mood cycles and nonresponsiveness to conventional drug treatments, including lithium carbonate, were given low doses (2.5 to 10.0 mg/24 hr) of clorgyline, a selective inhibitor of monoamine oxidase type A. In four patients, clorgyline, alone or in combination with lithium carbonate, prolonged the duration and lessened the severity of mood cycles. One patient experienced prolonged manias while receiving clorgyline therapy. Clorgyline-induced remissions have lasted from three to more than 12 months.



Author Affiliations

From the Clinical Psychobiology (Drs Potter, Wehr, Linnoila, and Goodwin) and Clinical Neuropharmacology (Dr Murphy) Branches, National Institute of Mental Health, Bethesda, Md.


Footnotes

Accepted for publication Nov 5, 1981.

Reprint requests to Clinical Psychobiology Branch, National Institute of Mental Health, Room 4S239, Bldg 10, 9000 Rockville Pike, Bethesda, MD 20205 (Dr Potter).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Rapid Cycling Bipolar Affective Disorder: II. Treatment of Refractory Rapid Cycling With High-Dose Levothyroxine: A Preliminary Study
Bauer and Whybrow
Arch Gen Psychiatry 1990;47:435-440.
ABSTRACT  

Selective Antidepressants and Cerebrospinal Fluid: Lack of Specificity on Norepinephrine and Serotonin Metabolites
Potter et al.
Arch Gen Psychiatry 1985;42:1171-1177.
ABSTRACT  

Five Antidepressant Treatments in Depressed Patients: Effects on Urinary Serotonin and 5-Hydroxyindoleacetic Acid Output
Linnoila et al.
Arch Gen Psychiatry 1984;41:688-692.
ABSTRACT  

Selective and Nonselective Monoamine Oxidase Inhibitors: Behavioral Disturbances During Their Administration to Depressed Patients
Pickar et al.
Arch Gen Psychiatry 1982;39:535-540.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1982 American Medical Association. All Rights Reserved.